Gottfried R. Von Keudell
Expertise in
22
conditions

Dr. Gottfried R. Von Keudell

Internal Medicine
330 Brookline Avenue, Shapiro 7, 
Boston, MA 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
22
conditions
330 Brookline Avenue, Shapiro 7, 
Boston, MA 

Overview

Gottfried Von Keudell is an Internal Medicine provider in Boston, Massachusetts. Dr. Von Keudell is highly rated in 22 conditions, according to our data. His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

His clinical research consists of co-authoring 35 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

University Medical Center Hamburg - Eppenddorf

Residency

University of Chicago Medical Center

Specialties

Internal Medicine

Licenses

Internal Medicine in MA

Board Certifications

American Board Of Internal Medicine

Fellowships

Beth Israel Deaconess Medical Center
University of Chicago Medical Center

Hospital Affiliations

Beth Israel Deaconess Medical Center

Languages Spoken

English
German

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Senior Whole Health
  • MEDICARE-MEDICAID PLAN
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 7 Less Insurance Carriers -

Locations

Beth Israel Deaconess Medical Center - Hematology/Oncology
330 Brookline Avenue, Shapiro 7, Boston, MA 02215
Other Locations
CHA - Medical Specialties - Whidden Campus
103 Garland Street, Everett, MA 02149
Cambridge Hospital
1493 Cambridge Street, Cambridge, MA 02139

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

An Exploratory Study to Correlate the Level of Cell-free DNA With Response to First-line Treatment in Patients With Follicular Lymphoma
An Exploratory Study to Correlate the Level of Cell-free DNA With Response to First-line Treatment in Patients With Follicular Lymphoma
Enrollment Status: Recruiting
Publish Date: August 19, 2025
Intervention Type: Diagnostic test, Other
Study Phase: Phase 1
A Phase I Trial of the Combination of Lenalidomide and Blinatumomab in Patients With Relapsed or Refractory Non-Hodgkins Lymphoma (NHL)
A Phase I Trial of the Combination of Lenalidomide and Blinatumomab in Patients With Relapsed or Refractory Non-Hodgkins Lymphoma (NHL)
Enrollment Status: Completed
Publish Date: November 26, 2025
Intervention Type: Biological, Drug
Study Drugs: Blinatumomab, Lenalidomide
Study Phase: Phase 1
A Phase II Trial of Response-Adapted Second-Line Therapy for Hodgkin Lymphoma Using Anti-PD-1 Antibody Nivolumab ? ICE Chemotherapy as a Bridge to Autologous Hematopoietic Cell Transplant (NICE Trial)
A Phase II Trial of Response-Adapted Second-Line Therapy for Hodgkin Lymphoma Using Anti-PD-1 Antibody Nivolumab ? ICE Chemotherapy as a Bridge to Autologous Hematopoietic Cell Transplant (NICE Trial)
Enrollment Status: Active_not_recruiting
Publish Date: October 20, 2025
Intervention Type: Drug, Biological, Other
Study Drugs: Carboplatin, Etoposide, Ifosfamide, Nivolumab
Study Phase: Phase 2
A Phase II Study of Pembrolizumab and Entinostat in Patients With Relapsed and Refractory Lymphomas
A Phase II Study of Pembrolizumab and Entinostat in Patients With Relapsed and Refractory Lymphomas
Enrollment Status: Active_not_recruiting
Publish Date: July 23, 2025
Intervention Type: Drug
Study Drugs: Entinostat, Pembrolizumab
Study Phase: Phase 2
A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma
A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2025
Intervention Type: Drug
Study Drugs: Rituximab, Venetoclax
Study Phase: Phase 2
Phase I Study of Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma
Phase I Study of Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma
Enrollment Status: Completed
Publish Date: April 25, 2025
Intervention Type: Drug
Study Drugs: Abexinostat, Ibrutinib
Study Phase: Phase 1
A Phase I, Open-label, Dose-escalation Study to Assess the Safety, Tolerability and Efficacy of the Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-Cell Non-Hodgkin Lymphoma (NHL)
A Phase I, Open-label, Dose-escalation Study to Assess the Safety, Tolerability and Efficacy of the Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-Cell Non-Hodgkin Lymphoma (NHL)
Enrollment Status: Active_not_recruiting
Publish Date: February 07, 2025
Intervention Type: Drug
Study Drugs: TGR-1202, Pembrolizumab
Study Phase: Phase 1
A Phase 1 Study of AG-636 in the Treatment of Subjects With Advanced Lymphoma
A Phase 1 Study of AG-636 in the Treatment of Subjects With Advanced Lymphoma
Enrollment Status: Terminated
Publish Date: August 25, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Randomized, Open-Label Phase 2 Study of Denintuzumab Mafodotin (SGN-CD19A) Plus Rituximab, Ifosfamide, Carboplatin, and Etoposide (19A+RICE) Chemotherapy vs. RICE in the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Who Are Candidates for Autologous Stem Cell Transplant
A Randomized, Open-Label Phase 2 Study of Denintuzumab Mafodotin (SGN-CD19A) Plus Rituximab, Ifosfamide, Carboplatin, and Etoposide (19A+RICE) Chemotherapy vs. RICE in the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Who Are Candidates for Autologous Stem Cell Transplant
Enrollment Status: Terminated
Publish Date: May 17, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials

35 Total Publications

Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: a pooled analysis.
Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: a pooled analysis.
Journal: Blood advances
Published: March 18, 2025
Similar Doctors
Adnan Majid
Expertise in
22
conditions
Dr. Adnan Majid
Internal Medicine
Expertise in
22
conditions
Dr. Adnan Majid
Internal Medicine

Beth Israel Deaconess Medical Center

185 Pilgrim Road, Farr Building, 1st Floor, 
Boston, MA 
 (0.3 miles away)
617-632-8252
Languages Spoken:
English, Spanish
See accepted insurances
Offers Telehealth

Adnan Majid is an Internal Medicine provider in Boston, Massachusetts. Dr. Majid is highly rated in 22 conditions, according to our data. His top areas of expertise are Tracheobronchomalacia, Pleural Effusion, Acquired Tracheomalacia, Advanced Bronchoscopy, and Endoscopy.

Nezam H. Afdhal
Expertise in
20
conditions
Dr. Nezam H. Afdhal
Internal Medicine
Expertise in
20
conditions
Dr. Nezam H. Afdhal
Internal Medicine

BIDMC - Division Of Gastroenterology/Liver Center

110 Francis Street, Suite 8E, 
Boston, MA 
 (0.3 miles away)
617-632-1070
Languages Spoken:
English, Farsi
See accepted insurances

Nezam Afdhal is an Internal Medicine provider in Boston, Massachusetts. Dr. Afdhal is highly rated in 20 conditions, according to our data. His top areas of expertise are Hepatitis C, Hepatitis, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Endoscopy.

Expertise in
22
conditions
Dr. Gabriela Hobbs
Internal Medicine
Expertise in
22
conditions
Dr. Gabriela Hobbs
Internal Medicine

Massachusetts General Hospital

55 Fruit St, 
Boston, MA 
 (2.5 miles away)
617-724-1124
Experience:
18+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Gabriela Hobbs is an Internal Medicine provider in Boston, Massachusetts. Dr. Hobbs has been practicing medicine for over 18 years is highly rated in 22 conditions, according to our data. Her top areas of expertise are Myeloproliferative Neoplasms (MPN), Myelofibrosis, Polycythemia Vera, Bone Marrow Aspiration, and Bone Marrow Transplant.

Frequently Asked Questions about Dr. Gottfried R. Von Keudell

How do I make an appointment with Dr. Gottfried R. Von Keudell?

You can book an appointment with Dr. Gottfried R. Von Keudell by calling their office at 617-667-9920. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Gottfried R. Von Keudell a top-rated expert for Follicular Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gottfried R. Von Keudell is classified as an Elite expert for Follicular Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gottfried R. Von Keudell specialize in?

While Dr. Gottfried R. Von Keudell is a Internal Medicine, they have specific expertise in Follicular Lymphoma, Non-Hodgkin Lymphoma, and Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Gottfried R. Von Keudell participate in research or clinical trials?

Yes. Dr. Gottfried R. Von Keudell has published 35 articles and abstracts on conditions like Follicular Lymphoma. You can view a list of Dr. Gottfried R. Von Keudell's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Gottfried R. Von Keudell accept my insurance?

Dr. Gottfried R. Von Keudell accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-667-9920 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Von Keudell's expertise for a condition
ConditionClose
View All 15 Advanced Conditions
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile